Nature-inspired metaheuristics for optimizing dose-finding and computationally challenging clinical trial designs

Area of Science:

• Computational science and biostatistics
• Clinical trial methodology
• Optimization algorithms

Background:

• Metaheuristics are widely used for optimization but underutilized in clinical trial design.
• Existing clinical trial designs often lack joint consideration of toxicity and efficacy.
• There is a need for advanced computational methods to address complex trial design challenges.

Purpose of the Study:

• To provide an overview of metaheuristics and their application in clinical trial design.
• To apply the particle swarm optimization (PSO) algorithm to develop novel phase I/II clinical trial designs.
• To demonstrate the utility of metaheuristics in optimizing dose-finding studies and enhancing trial flexibility.

Main Methods:

• Overview of metaheuristics, focusing on nature-inspired algorithms.
• Application of the particle swarm optimization (PSO) algorithm for phase I/II design.
• Development of optimal dose-finding studies using a continuation-ratio model with constraints.
• Extension of existing designs to more complex, multi-stage, and Bayesian optimal phase II trials.

Main Results:

• PSO effectively designs phase I/II trials that balance toxicity and efficacy.
• The proposed PSO-based design enhances patient safety by avoiding doses above the maximum tolerated dose.
• Accurate estimation of the optimal biological dose (OBD) is achieved.
• Metaheuristics successfully address computationally intensive design problems, including multi-stage and flexible Bayesian designs.

Conclusions:

• Metaheuristics, particularly PSO, offer a powerful approach to optimize clinical trial design.
• These methods improve patient safety and the accuracy of dose selection in early-phase trials.
• Metaheuristics provide a flexible framework for tackling complex and computationally demanding clinical trial design challenges.